Daily Judi: Monday, October 10, 2022
Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:
Merck's cardiovascular drug, sotatercept, acquired in a multi-billion dollar purchase of Acceleron Pharma last year, passed a phase 3 clinical trial. (Fierce Biotech)
CenterWatch examines a new survey of the home visit component of decentralized clinical trials.
VatorNews speaks with Lauren Broffman, Ph.D., Director of Clinical Research at Ro, about issues with Alzheimer's clinical trials, and a new initiative with the National Institutes of Health.
The CNS Summit 2022 will be held on November 17–20, in Boca Raton, Florida. Created as "a community of innovators and industry leaders who are not afraid to challenge the status quo," CNS was founded in 2009 to advance clinical development, focused on collaboration and innovation. Team Judi will be there!
Our Culture
“The final product that the client receives is fully configured to their trial, their forms, their workflow.”
–Jess, Program Manager
About Judi
Judi empowers and enhances the world's clinical trial ecosystems. Our cloud-based platform has 120,000 users across 168 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 Type II certified collaboration platform.